PDS Historical Balance Sheet

PDSB Stock

USD 1.24 0.01 0.80%

Trend analysis of PDS Biotechnology Corp balance sheet accounts such as Property Plant And Equipment Net of 286.4 K, Accounts Payable of 8.4 M, Cash of 61.8 M or Non Current Assets Total of 286.4 K provides information on PDS Biotechnology's total assets, liabilities, and equity, which is the actual value of PDS Biotechnology Corp to its prevalent stockholders. By breaking down trends over time using PDS Biotechnology balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining PDS Biotechnology Corp latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether PDS Biotechnology Corp is a good buy for the upcoming year.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

About PDS Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of PDS Biotechnology Corp at a specified time, usually calculated after every quarter, six months, or one year. PDS Biotechnology Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of PDS Biotechnology and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which PDS currently owns. An asset can also be divided into two categories, current and non-current.

PDS Biotechnology Balance Sheet Chart

At present, PDS Biotechnology's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 16.5 M, whereas Total Assets are forecasted to decline to about 64.9 M.

Total Assets Other Current Liab Total Current Liabilities Property Plant And Equipment Net

Add Fundamental

Total Assets

Total assets refers to the total amount of PDS Biotechnology assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in PDS Biotechnology Corp books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on PDS Biotechnology balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of PDS Biotechnology Corp are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Property Plant And Equipment Net

The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.

Most accounts from PDS Biotechnology's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into PDS Biotechnology Corp current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PDS Biotechnology Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.

	2022	2023	2024	2025 (projected)
Other Current Liabilities	8.3M	2.4M	2.8M	3.7M
Total Assets	77.0M	59.4M	68.3M	64.9M

Other Current Liab Total Assets

PDS Biotechnology balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Short Long Term Debt Total	Current Deferred Revenue	Short Term Debt	Other Assets
Total Assets		0.58	0.62	0.95	0.73	-0.96	-0.53	0.41	1.0	0.71	0.03	1.0	-0.62	0.8	0.24	-0.29	0.32	0.81	-0.03	0.75	1.0	0.79	0.51	0.15	0.41	-0.33
Other Current Liab	0.58		0.55	0.53	0.34	-0.49	-0.72	0.12	0.58	0.33	0.1	0.58	-0.6	0.7	0.28	-0.15	0.43	0.73	0.07	0.34	0.59	0.68	0.49	0.04	0.18	-0.29
Total Current Liabilities	0.62	0.55		0.47	0.24	-0.4	-0.79	0.89	0.61	0.22	-0.2	0.61	-0.59	0.71	0.68	-0.04	0.61	0.75	0.25	0.27	0.62	0.76	0.92	0.64	0.9	-0.38
Total Stockholder Equity	0.95	0.53	0.47		0.66	-0.97	-0.47	0.27	0.95	0.64	-0.04	0.95	-0.62	0.79	0.19	-0.55	0.27	0.79	-0.33	0.67	0.95	0.76	0.32	0.05	0.28	-0.15
Property Plant And Equipment Net	0.73	0.34	0.24	0.66		-0.75	-0.26	0.12	0.73	1.0	0.59	0.73	-0.37	0.39	-0.35	0.02	-0.12	0.5	0.16	1.0	0.72	0.37	0.18	-0.19	0.07	-0.2
Net Debt	-0.96	-0.49	-0.4	-0.97	-0.75		0.39	-0.2	-0.96	-0.74	-0.1	-0.96	0.54	-0.72	-0.06	0.4	-0.16	-0.73	0.19	-0.76	-0.96	-0.69	-0.26	0.01	-0.22	0.25
Retained Earnings	-0.53	-0.72	-0.79	-0.47	-0.26	0.39		-0.56	-0.52	-0.26	-0.11	-0.52	0.63	-0.82	-0.44	0.26	-0.45	-0.89	-0.03	-0.28	-0.53	-0.84	-0.64	-0.34	-0.57	0.38
Accounts Payable	0.41	0.12	0.89	0.27	0.12	-0.2	-0.56		0.41	0.1	-0.27	0.41	-0.4	0.46	0.67	0.07	0.5	0.49	0.28	0.15	0.42	0.53	0.85	0.74	0.95	-0.3
Cash	1.0	0.58	0.61	0.95	0.73	-0.96	-0.52	0.41		0.71	0.03	1.0	-0.61	0.8	0.24	-0.3	0.32	0.81	-0.04	0.74	1.0	0.79	0.5	0.15	0.41	-0.33
Non Current Assets Total	0.71	0.33	0.22	0.64	1.0	-0.74	-0.26	0.1	0.71		0.62	0.71	-0.35	0.38	-0.37	0.03	-0.15	0.48	0.17	1.0	0.7	0.35	0.16	-0.2	0.05	-0.21
Non Currrent Assets Other	0.03	0.1	-0.2	-0.04	0.59	-0.1	-0.11	-0.27	0.03	0.62		0.03	0.09	-0.12	-0.72	0.35	-0.54	0.06	0.31	0.58	0.01	-0.15	-0.24	-0.34	-0.31	-0.31
Cash And Short Term Investments	1.0	0.58	0.61	0.95	0.73	-0.96	-0.52	0.41	1.0	0.71	0.03		-0.61	0.8	0.24	-0.3	0.32	0.81	-0.04	0.74	1.0	0.79	0.5	0.15	0.41	-0.33
Net Receivables	-0.62	-0.6	-0.59	-0.62	-0.37	0.54	0.63	-0.4	-0.61	-0.35	0.09	-0.61		-0.75	-0.46	0.39	-0.75	-0.72	0.16	-0.38	-0.62	-0.75	-0.4	-0.21	-0.35	-0.12
Common Stock Total Equity	0.8	0.7	0.71	0.79	0.39	-0.72	-0.82	0.46	0.8	0.38	-0.12	0.8	-0.75		0.53	-0.45	0.55	0.96	-0.15	0.41	0.81	1.0	0.56	0.3	0.47	-0.27
Common Stock Shares Outstanding	0.24	0.28	0.68	0.19	-0.35	-0.06	-0.44	0.67	0.24	-0.37	-0.72	0.24	-0.46	0.53		-0.14	0.76	0.37	0.03	-0.32	0.26	0.56	0.69	0.63	0.64	-0.13
Non Current Liabilities Total	-0.29	-0.15	-0.04	-0.55	0.02	0.4	0.26	0.07	-0.3	0.03	0.35	-0.3	0.39	-0.45	-0.14		-0.16	-0.42	0.94	0.02	-0.3	-0.42	0.19	0.01	0.0	-0.42
Other Current Assets	0.32	0.43	0.61	0.27	-0.12	-0.16	-0.45	0.5	0.32	-0.15	-0.54	0.32	-0.75	0.55	0.76	-0.16		0.46	0.05	-0.1	0.33	0.58	0.57	0.45	0.46	0.15
Other Stockholder Equity	0.81	0.73	0.75	0.79	0.5	-0.73	-0.89	0.49	0.81	0.48	0.06	0.81	-0.72	0.96	0.37	-0.42	0.46		-0.11	0.52	0.82	0.96	0.57	0.29	0.51	-0.32
Total Liab	-0.03	0.07	0.25	-0.33	0.16	0.19	-0.03	0.28	-0.04	0.17	0.31	-0.04	0.16	-0.15	0.03	0.94	0.05	-0.11		0.17	-0.04	-0.11	0.44	0.12	0.23	-0.53
Property Plant And Equipment Gross	0.75	0.34	0.27	0.67	1.0	-0.76	-0.28	0.15	0.74	1.0	0.58	0.74	-0.38	0.41	-0.32	0.02	-0.1	0.52	0.17		0.73	0.39	0.21	-0.16	0.11	-0.21
Total Current Assets	1.0	0.59	0.62	0.95	0.72	-0.96	-0.53	0.42	1.0	0.7	0.01	1.0	-0.62	0.81	0.26	-0.3	0.33	0.82	-0.04	0.73		0.8	0.51	0.16	0.42	-0.33
Common Stock	0.79	0.68	0.76	0.76	0.37	-0.69	-0.84	0.53	0.79	0.35	-0.15	0.79	-0.75	1.0	0.56	-0.42	0.58	0.96	-0.11	0.39	0.8		0.61	0.36	0.53	-0.28
Short Long Term Debt Total	0.51	0.49	0.92	0.32	0.18	-0.26	-0.64	0.85	0.5	0.16	-0.24	0.5	-0.4	0.56	0.69	0.19	0.57	0.57	0.44	0.21	0.51	0.61		0.61	0.8	-0.42
Current Deferred Revenue	0.15	0.04	0.64	0.05	-0.19	0.01	-0.34	0.74	0.15	-0.2	-0.34	0.15	-0.21	0.3	0.63	0.01	0.45	0.29	0.12	-0.16	0.16	0.36	0.61		0.71	-0.19
Short Term Debt	0.41	0.18	0.9	0.28	0.07	-0.22	-0.57	0.95	0.41	0.05	-0.31	0.41	-0.35	0.47	0.64	0.0	0.46	0.51	0.23	0.11	0.42	0.53	0.8	0.71		-0.32
Other Assets	-0.33	-0.29	-0.38	-0.15	-0.2	0.25	0.38	-0.3	-0.33	-0.21	-0.31	-0.33	-0.12	-0.27	-0.13	-0.42	0.15	-0.32	-0.53	-0.21	-0.33	-0.28	-0.42	-0.19	-0.32

Click cells to compare fundamentals

PDS Biotechnology Account Relationship Matchups

PDS Biotechnology balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	30.9M	67.2M	77.0M	59.4M	68.3M	64.9M
Other Current Liab	1.7M	2.2M	8.3M	2.4M	2.8M	3.7M
Total Current Liabilities	3.3M	3.8M	9.8M	13.6M	15.7M	16.5M
Total Stockholder Equity	27.1M	63.2M	44.0M	26.1M	30.1M	43.3M
Property Plant And Equipment Net	553.1K	357.7K	527.5K	335.0K	301.5K	286.4K
Net Debt	(28.2M)	(64.8M)	(50.3M)	(32.7M)	(37.6M)	(39.5M)
Retained Earnings	(43.8M)	(60.7M)	(101.6M)	(144.5M)	(130.1M)	(136.6M)
Accounts Payable	1.4M	1.3M	1.2M	7.0M	8.0M	8.4M
Cash	28.8M	65.2M	73.8M	56.6M	65.0M	61.8M
Non Current Assets Total	553.1K	357.7K	527.5K	335.0K	301.5K	286.4K
Cash And Short Term Investments	28.8M	65.2M	73.8M	56.6M	65.0M	61.8M
Common Stock Total Equity	10.6K	1.7K	7.3K	10.0K	11.4K	7.5K
Common Stock Shares Outstanding	16.7M	25.6M	28.6M	31.0M	35.6M	37.4M
Liabilities And Stockholders Equity	30.9M	67.2M	77.0M	59.4M	68.3M	64.9M
Non Current Liabilities Total	490.4K	231.4K	23.2M	19.6M	17.7M	10.4M
Other Current Assets	1.5M	1.6M	2.7M	2.5M	2.9M	1.6M
Other Stockholder Equity	70.9M	123.9M	145.6M	170.6M	196.2M	136.7M
Total Liab	3.8M	4.0M	33.0M	33.3M	29.9M	15.7M
Property Plant And Equipment Gross	553.1K	357.7K	527.5K	467.8K	421.0K	400.0K
Total Current Assets	30.3M	66.8M	76.5M	59.1M	67.9M	63.4M
Common Stock	7.3K	9.4K	10.0K	10.9K	12.6K	8.1K
Capital Surpluse	222.6M	40.6M	70.9M	145.6M	131.0M	122.2M
Property Plant Equipment	21.1K	553.1K	357.7K	527.5K	474.8K	438.1K
Net Tangible Assets	11.7M	27.1M	63.2M	44.0M	50.6M	53.1M
Net Invested Capital	27.1M	63.2M	67.0M	49.8M	57.3M	52.1M
Net Working Capital	27.1M	63.1M	66.7M	45.4M	52.2M	50.2M
Capital Stock	7.3K	9.4K	10.0K	10.9K	12.6K	9.2K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether PDS Biotechnology Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of PDS Biotechnology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Pds Biotechnology Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Pds Biotechnology Corp Stock:

How To Invest In PDS

Details

Is PDS Stock a good investment?

Details

What is PDS Biotechnology's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of PDS Biotechnology. If investors know PDS will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about PDS Biotechnology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.18)

Return On Assets

(0.45)

Return On Equity

(1.74)

The market value of PDS Biotechnology Corp is measured differently than its book value, which is the value of PDS that is recorded on the company's balance sheet. Investors also form their own opinion of PDS Biotechnology's value that differs from its market value or its book value, called intrinsic value, which is PDS Biotechnology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because PDS Biotechnology's market value can be influenced by many factors that don't directly affect PDS Biotechnology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between PDS Biotechnology's value and its price as these two are different measures arrived at by different means. Investors typically determine if PDS Biotechnology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, PDS Biotechnology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

PDS Historical Balance Sheet

About PDS Balance Sheet Analysis

PDS Biotechnology Balance Sheet Chart

Total Assets

Total Current Liabilities

Property Plant And Equipment Net

PDS Biotechnology balance sheet Correlations

PDS Biotechnology Account Relationship Matchups

High Positive Relationship

High Negative Relationship

PDS Biotechnology balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Non Current Assets Total	+ 1.0	Property Plant And Equipment Net
Property Plant And Equipment Gross	+ 1.0	Property Plant And Equipment Net
Cash And Short Term Investments	+ 1.0	Cash

Net Debt	- 0.97	Total Stockholder Equity
Total Current Assets	- 0.96	Net Debt
Cash And Short Term Investments	- 0.96	Net Debt
Cash	- 0.96	Net Debt
Net Debt	- 0.96	Total Assets
Other Stockholder Equity	- 0.89	Retained Earnings